Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
INO — Inovio Pharmaceuticals, Inc.
NASDAQ
FULL STOCK PAGE →

Q4 2025 Earnings Call Summary

MAR 12, 2026
REVENUE
$0
EPS
$0.05 +106.3%
FREE CASH FLOW
-$19.5M +9.9%

No summary has been written for this call yet.